Mainstream Pain Pills Proven WORTHLESS
How many times have you seen the commercials on TV?
Poor guys and gals grabbing at their backs and wincing in pain… but then they pop some ibuprofen (Advil) or naproxen (Aleve) and they’re good as new.
Big Pharma has made billions selling these nonsteroidal anti-inflammatory drugs (NSAIDs) to millions of Americans suffering from back pain.
And how we know it’s a total crock.
Because a new study proves that NSAIDs do next to NOTHING for back pain — and may be seriously harming your gut instead.
Researchers from Australia recently wrapped up a massive study that looked at the use of NSAIDs like ibuprofen and naproxen for back pain.
And you would have been better off taking nothing.
The study found that only one in six people with back pain experienced any relief from NSAIDs — and in many cases, the difference was too small to actually matter.
Can you imagine that? The drug companies have gotten rich selling these pills… and our government hasn’t done a thing to slow the gravy train.
And meanwhile, they’re practically worthless! Worse still, the people taking NSAIDs were more than twice as likely to suffer gastrointestinal problems, which are very common with these meds.
Unfortunately, Tylenol (acetaminophen) isn’t any better, either, according to previous research.
Of course, that doesn’t mean you should leave your back pain untreated. You just need to try a drug-free approach.
The herbal supplement devil’s claw (which comes from an African fruit) has been proven to provide real back pain relief you can feel.
In a four-week study, nearly 200 men and women with back pain tried taking devil’s claw daily. And after just a month, they had less pain and had even cut down their painkiller use.
And in another study on back pain, devil’s claw performed just as well as one of the most powerful prescription pain drugs on the market (and it’s much safer).
Devil’s claw supplements are easy to find online. You can pick it up from suppliers like Swanson or Nature’s Way for less than $10 a month.